• Nenhum resultado encontrado

J. Braz. Chem. Soc. vol.23 número11

N/A
N/A
Protected

Academic year: 2018

Share "J. Braz. Chem. Soc. vol.23 número11"

Copied!
10
0
0

Texto

Loading

Imagem

Table 1. Composition of the lipid-based colloidal suspensions
Table 2. Mean particle size (nm) and polydispersity index (PDI) measured by DLS for the lipid-based colloidal suspensions
Figure 1. Correlation function and hydrodynamic radius (R h ) obtained using an ALV-5000 at 90 o  scattering angle for lipid-based nanocarriers containing  2.5 wt.% Poloxamer 188 (left column) or 0.25 wt.% PEG 660 stearate (right column).
Figure 2. TEM images of NE nanocarriers prepared in the presence of  Poloxamer 188 (a, c) and PEG 660-stearate (b, d) in the aqueous phase;
+3

Referências

Documentos relacionados

These results demonstrated that the enzymolysis of the BSA-Au nanoclusters by trypsin specifically caused the decrease in fluorescence intensity, and the BSA-Au nanoclusters could

the binding process and to distinguish the binding modes is the combination of absorption spectroscopy detecting the total concentration of adsorbed on DNA molecules and

The structural characterization of the compounds isolated was established based on infrared spectroscopy, mass spectrometry, one- and two-dimensional nuclear magnetic resonance,

For example, the higher concentration of coprostanol in the Summer sampling at stations Ig12 and Ig13 (Table 1), located in the secondary channels of the Iguaçu River, suggests

In this work, quantitative structure-property relationship (QSPR) models using multiple linear regression (MLR) and support vector machine (SVM) methods were setup to excavate

In the present work, CP was encapsulated in nanostructured lipid carriers (NLCs) to increase drug retention in the outer skin layers and improve the safety of topical therapy..

A simple and quick analytical method to quantify the amount of halcinonide encapsulated into lipid nanoparticles, such as polymeric lipid-core nanoparticles and solid lipid

For the determination of pharmacokinetic and brain targeting parameters after intranasal administration of haloperidol loaded solid lipid nanoparticles (HP-SLNs) and plain drug